Login / Signup

Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors.

Jacqueline T BrownYuan LiuJulie M ShabtoDylan MartiniDeepak RavindranathanEmilie Elise HitronGreta Anne RusslerSarah CaulfieldLauren YantorniShreyas Subhash JoshiHaydn KissickKenneth OganBassel NazhaBradley C CarthonOmer KucukWayne B HarrisViraj A MasterMehmet Asim Bilen
Published in: Journal for immunotherapy of cancer (2022)
The mGPS is prognostic in this cohort of patients with mRCC treated with ICI as monotherapy or in combination. These results warrant external and prospective validation.
Keyphrases
  • metastatic renal cell carcinoma
  • combination therapy
  • randomized controlled trial
  • clinical trial
  • study protocol